MI192 induced epigenetic reprogramming enhances the therapeutic efficacy of human bone marrows stromal cells for bone regeneration

Man, K, Mekhileri, NV, Lim, KS et al. (3 more authors) (2021) MI192 induced epigenetic reprogramming enhances the therapeutic efficacy of human bone marrows stromal cells for bone regeneration. Bone, 153. 116138. ISSN 8756-3282

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2021 Elsevier Inc. All rights reserved. This is an author produced version of an article published in Bone. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: HDAC inhibitor; Histone deacetylase; Osteogenic differentiation; MI192; Bone marrow stromal cells; Bone tissue engineering; Epigenetics; Additive manufacturing
Dates:
  • Published: December 2021
  • Accepted: 27 July 2021
  • Published (online): 31 July 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Dentistry (Leeds) > Oral Biology (Leeds)
Funding Information:
FunderGrant number
Changzhou Kanghui Medical Innovation CoNo Ext Ref Given
EU - European Union318553
Depositing User: Symplectic Publications
Date Deposited: 13 Aug 2021 09:57
Last Modified: 13 Aug 2021 09:57
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.bone.2021.116138

Download

Accepted Version


Embargoed until: 31 July 2022

Filename: BMSC MI192 paper-210721-KM-revision final.pdf

Licence: CC-BY-NC-ND 4.0

Request a copy

file not available

Share / Export

Statistics